Transcendent Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$352K Sell
1,438
-29
-2% -$6.75K 0.16% 88
2025
Q4
$304K Buy
1,467
+156
+12% +$30.8K 0.14% 95
2025
Q3
$243K Buy
+1,311
New +$225K 0.11% 112
2025
Q2
Sell
-1,288
Closed -$214K 106
2025
Q1
$214K Buy
1,288
+105
+9% +$16.4K 0.12% 84
2024
Q4
$171K Hold
1,183
0.09% 109
2024
Q3
$192K Sell
1,183
-7
-0.6% -$1.11K 0.1% 105
2024
Q2
$174K Buy
1,190
+7
+0.6% +$1.04K 0.1% 95
2024
Q1
$187K Hold
1,183
0.11% 97
2023
Q4
$185K Buy
+1,183
New +$181K 0.12% 77

Other funds holding JNJ

Transcendent Capital Group's JNJ Position: Q1 2026 in Review

Transcendent Capital Group reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $6.75K and leaving 1,438 shares worth $352K. The position accounts for 0.16% of the portfolio, ranked #88.

Transcendent Capital Group first reported a position in JNJ in Q4 2023 and has held it in 9 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Transcendent Capital Group held 1,438 shares of Johnson & Johnson worth $352K as of Q1 2026.
  • Transcendent Capital Group sold 29 Johnson & Johnson shares in Q1 2026, an estimated $6.75K.
  • Johnson & Johnson made up 0.16% of Transcendent Capital Group's portfolio in Q1 2026, its #88 holding.
  • Transcendent Capital Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 9 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Transcendent Capital Group's 13F filing for Q1 2026, filed 27 Apr 2026.